Official announcements
Recall
|
Veterinary Medicines
|
25/03/2022
Recall due to leakage at the base of the injector
Enforcement
|
23/03/2022
The product called "Viazene Bleu" is marketed as an all-natural dietary supplement specifically for men. However, it is to be classified as an illegal medicinal product.
Enforcement
|
23/03/2022
The product called "Maxviril" is marketed as a purely herbal food supplement especially for men. However, it is to be classified as an illegal medicinal product.
CHMP Monthly News
|
17/03/2022
Up-to-date information from the 21.02-24.02.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Monthly News
|
17/03/2022
Up-to-date information from the 24.01.-27.01.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
Recall
|
Medicines
|
08/03/2022
Recall due to nitrosamine contamination above the permitted daily dose
messages in brief
|
18/02/2022
Reporting suspected adverse reactions to veterinary drugs is possible using an online form.
messages in brief
|
14/02/2022
With the AMG amendment of 14.02.2022, § 21(2) was changed to the effect that the BASG must now be notified four months (instead of the previous two months) in advance of a temporary or permanent discontinuation of the marketing of medicinal products.
messages in brief
|
07/02/2022
The new Veterinary Medicinal Products Regulation is to be applied as of 28.01.2022.
messages in brief
|
31/01/2022
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.